Krystal Biotech, Inc. KRYS Accrued construction in progress
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept krys:AccruedConstructionInProgressCurrent.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s accrued construction in progress.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s accrued construction in progress?
- Krystal Biotech, Inc. (KRYS) reported accrued construction in progress of $784K in Q1 2026.
- How has Krystal Biotech, Inc.'s accrued construction in progress changed year-over-year?
- Krystal Biotech, Inc.'s accrued construction in progress decreased by 41.8% year-over-year, from $1.35M to $784K.
- What is the long-term trend for Krystal Biotech, Inc.'s accrued construction in progress?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s accrued construction in progress has grown at a 15.8% compound annual growth rate (CAGR), from $1.05M to $2.19M.